Palisade Bio (PALI) Short-term Investments (2014 - 2017)

Palisade Bio (PALI) has reported Short-term Investments for 4 consecutive years, with $5.0 million the latest figure, recorded in Q4 2017.

• In Q4 2017, Short-term Investments changed 0.0% year-over-year to $5.0 million; the TTM figure through Dec 2017 stood at $5.0 million (changed 0.0% YoY), while the FY2017 annual figure was $5.0 million, changed 0.0% from the prior year.
• Short-term Investments was little changed at $5.0 million in Q4 2017 per PALI's latest filing, from $5.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $15.0 million in Q1 2015 and bottomed at $5.0 million in Q4 2016.
• Historically, Short-term Investments has averaged $9.8 million across 4 years, with a median of $7.5 million in 2015.
• On a YoY basis, Short-term Investments climbed as much as 0.22% in 2015 and fell as far as 66.57% in 2015.
• Palisade Bio's Short-term Investments stood at $15.0 million in 2014, then sank by 49.91% to $7.5 million in 2015, then plunged by 33.49% to $5.0 million in 2016, then changed by 0.0% to $5.0 million in 2017.
• Business Quant data shows PALI's Short-term Investments at $5.0 million in Q4 2017, $5.0 million in Q3 2017, and $5.0 million in Q2 2017.